One hundred and seventy-six metastatic breast cancer patients were randomised to receive docetaxel ( __number__ mg m( __number__ )) every __number__ weeks or __number__ -fluorouracil+vinorelbine: __number__ -fluorouracil ( __number__ mg m( __number__ ) per day continuous infusion) D __number__ plus vinorelbine ( __number__ mg m( __number__ )) D __number__ and D __number__ of each __number__ -week cycle.